BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//RE4CH - ECPv6.1.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RE4CH
X-ORIGINAL-URL:https://www.research-for-children.de
X-WR-CALDESC:Events for RE4CH
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200407T170000
DTEND;TZID=Europe/Berlin:20200407T170100
DTSTAMP:20261104T033533
CREATED:20190828T075317Z
LAST-MODIFIED:20190828T075458Z
UID:617-1586278800-1586278860@www.research-for-children.de
SUMMARY:Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data (SC1-BHC-06-2020)
DESCRIPTION:Specific Challenge: \n\n\n\nThe  availability of appropriate decision support tools for healthcare  practitioners can promote uptake of personalised medicine in health  care. There is a need to carry out research activities aiming to develop  and validate such decision tools that would integrate available and/or  emerging diagnostic means for the area concerned\, enabling increased  precision of diagnostics and clinical decision making. On-going progress  in the fields of bioinformatics and biostatistics\, advanced analytical  tools (e.g. machine learning) up to Artificial Intelligence (AI)  solutions\, should make possible the development of devices\, platforms or  novel approaches leading to highly personalised diagnosis\, based on the  integration of data available from various sources. The ultimate result  would be a detailed health status assessment from a multitude of  viewpoints\, in a systemic way and easy to use for clinical purposes\,  leading to better diagnostic accuracy\, increased effectiveness and  efficiency of treatments. Novel hardware enabling truly innovative\,  integrative diagnostic platforms can also be considered.  \n\n\n\nScope: \n\n\n\nProposals should \ndevelop tools\, platforms or services that will use information provided \nby most relevant diagnostic means for a particular area\, resulting in an\n accurate\, detailed\, structured\, systemic and prioritised assessment of \nthe health status in a patient. The proposed solutions should integrate \nvarious data sources such as medical records\, in vitro and/or in vivo\n diagnostics\, medical imaging\, -omics data\, functional tests \n(lab-on-a-chip) etc.\, while taking into account the actual needs of \nhealthcare practitioners\, and should be tested and validated in \nreal-life settings in pilot centres\, facilitating future Health \nTechnology Assessment. These tools/platforms/services should contribute \nto improving diagnosis and clinical decision\, not only integrate \nexisting data\, and should involve intelligent human-computer interface \nsolutions to facilitate its daily use in clinical practice. Any medical \ndata relevant for a particular disease (textual data\, numerical \nmeasurements\, recorded signals\, images etc.) may be considered. The aim \nis to steer the development of solutions towards concrete patient and \npublic sector needs\, having the citizen and healthcare providers at the \ncentre. Careful attention should be paid to appropriately addressing \nethical and legal concerns\, providing adequate information to health \nprofessionals and patients to support informed decisions\, and ensuring \ndata safety and privacy\, in line with existing European and \ninternational standards and legislation. Gender and sex differences \nshould be taken into consideration when relevant. \n\n\n\nThe Commission  considers that proposals requesting a contribution from the EU of  between EUR 8 and 15 million would allow this specific challenge to be  addressed appropriately. Nonetheless\, this does not preclude submission  and selection of proposals requesting different amounts.  \n\n\n\nExpected Impact: \n\n\n\nIncrease  EU’s capacity to innovate in the area of medical instruments  technologies through the development of new diagnostic tools\, platforms  or services integrating various diagnostic data and providing quick\,  detailed\, accurate and highly personalised diagnostics for optimal  decision in clinical practice.Improve the quality and  sustainability of healthcare systems through quicker and more  encompassing diagnosis of medical conditions\, leading to quicker and  better clinical decisions and timely delivery of effective personalised  treatments\, with reduction of errors and delays (and costs associated to  them).Contribute to the growth of the European diagnostics sector\, in particular for SMEs.Reinforce EU’s role among world leaders in the production of medical diagnostic devices.\n\n\n\nFor more information\, please visit the European Commission website.
URL:https://www.research-for-children.de/event/digital-diagnostics-developing-tools-for-supporting-clinical-decisions-by-integrating-various-diagnostic-data-sc1-bhc-06-2020/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200407T000000
DTEND;TZID=Europe/Berlin:20200407T235959
DTSTAMP:20261104T033533
CREATED:20191210T111618Z
LAST-MODIFIED:20191210T111621Z
UID:1340-1586217600-1586303999@www.research-for-children.de
SUMMARY:Horizon 2020: Use of Real-World Data to advance research on the management of complex chronic conditions
DESCRIPTION:Specific Challenge: \n\n\n\nThe \nnumber of people with chronic illness is growing and almost half of them\n have multiple chronic conditions. Patients with complex chronic \nconditions (CCCs) have chronic multi-morbidities or chronic disease \ncomplications that require the attention of multiple health care \nproviders or facilities as well as home-based care. A patient with CCC \npresents to the health care system with unique constellation of needs\, \ndisabilities\, or functional limitations[1].  \n\n\n\nManaging\n patients with complex chronic conditions therefore needs approaches \nthat ensure multi-disciplinary\, personalised and well accepted by the \npatient ways of care and monitoring. \n\n\n\nThe controlled randomised \nclinical trials on chronic diseases provide important information that \ncan be translated in the daily clinical practice\, but they often do not \ncomprise sufficient breadth and depth commensurate to the complexity of \ndiseases\, and to the degree of personalisation of treatment needed. \n\n\n\nReal\n World Data (referring specifically to any type of data not collected in\n a randomised clinical trial) can complement these to fill the knowledge\n gap between controlled clinical trials results and clinical practice \nneeds in real environments. They can provide new insights into disease \npatterns and help improve the safety and effectiveness of health \ninterventions.  \n\n\n\nTapping into this rich resource of ‘real world  data’ issued from daily clinical practice\, either collected on a  permanent/regular basis by public bodies or through devices and mobile  applications\, \, and smartly assembled in combination with clinical  studies\, should boost both output and relevance of controlled clinical  research results. \n\n\n\nFor more information please visit the EC website: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/sc1-dth-12-2020
URL:https://www.research-for-children.de/event/horizon-2020-use-of-real-world-data-to-advance-research-on-the-management-of-complex-chronic-conditions/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200407T000000
DTEND;TZID=Europe/Berlin:20200407T235900
DTSTAMP:20261104T033533
CREATED:20191210T111447Z
LAST-MODIFIED:20191210T111732Z
UID:1338-1586217600-1586303940@www.research-for-children.de
SUMMARY:Horizon 2020: Addressing low vaccine uptake
DESCRIPTION:Specific Challenge: \n\n\n\nVaccines\n are one of the most important medical breakthroughs in the last 100 \nyears. Every year vaccines save millions of people around the world from\n illness\, disability and death\, and they continue to be one of the most \ncost-effective ways to increase the health and wellbeing of their \ncitizens. Despite this\, vaccination uptake faces significant challenges \nacross Europe\, and these have increased in particular over the past 20 \nyears. Recent studies have shown Europe to be the world region with the \nmost negative views towards the safety and effectiveness of vaccines\, \nand the importance of childhood vaccination[1]. \n\n\n\nRecent\n figures on collected by the World Health Organization (WHO) show that \nin 2016 only one vaccine had a coverage rate of over 95% in Europe.[2] Seasonal influenza vaccination also remains significantly below the 75% coverage target for older age groups.[3] \n\n\n\nThus\,\n coverage for many vaccines is below the recommended limit. Due to the \nlow vaccine coverage rates\, several EU Member States have faced \nconsiderable outbreaks of vaccine-preventable diseases in recent years. \nFor example\, more than 14\,000 cases of measles were reported across the \nEU in 2017[4]\,\n which is more than three times the number of cases reported in 2016. \nDuring the same period 50 people in the EU died due to measles[5]. \n\n\n\nThese  figures highlight the urgent need to get to grips with vaccine uptake  issues\, whether uptake of existing or new vaccines. Research has an  essential role to play in understanding the underlying causes of poor  vaccine uptake\, including vaccine hesitancy\, and to develop strategies  and guidelines to help Member States and Associated countries increase  vaccination coverage. A detailed understanding of the obstacles to\, and  drivers of\, vaccination uptake in various settings is necessary to  provide appropriate recommendations. \n\n\n\nFor more information please visit the EC webpage: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/sc1-bhc-33-2020
URL:https://www.research-for-children.de/event/horizon-2020-addressing-low-vaccine-uptake/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200407T000000
DTEND;TZID=Europe/Berlin:20200407T235959
DTSTAMP:20261104T033533
CREATED:20191210T111317Z
LAST-MODIFIED:20191210T111319Z
UID:1336-1586217600-1586303999@www.research-for-children.de
SUMMARY:Horizon 2020: Coordinating and supporting research on the human microbiome in Europe and beyond
DESCRIPTION:Specific Challenge: \n\n\n\nIntegration\n and application of metagenomics data from the human microbiome has \nshown large potential for personalised medicine approaches\, although \ncausal relationships and confounders are still largely unknown. \nComparable information and details about microbiome composition and \nfunctionality in healthy citizen and patients are very valuable to \ncomplete the picture i.e. to better understand the healthy microbiome \nand to predict its development. \n\n\n\nThe number of European and  international projects and initiatives is increasing but their results  and data cannot be properly compared as they have different underlying  methods\, standards and operating procedures. The International Human  Microbiome Consortium (IHMC) as well as other current initiatives aim to  strengthen international cooperation\, to increase data comparability  and to agree common standards\, procedures and methods. There is a need  to avoid having the same research carried out multiple times at  different places and to better agree at European and at international  level. This collaboration should increase coherence and data  comparability to better exploit existing microbiome data and clinical  information in a standardised way. \n\n\n\n \n\n\n\nFor more information please visit the EC website: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/sc1-hco-17-2020
URL:https://www.research-for-children.de/event/horizon-2020-coordinating-and-supporting-research-on-the-human-microbiome-in-europe-and-beyond/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200323T130000
DTEND;TZID=Europe/Berlin:20200323T140000
DTSTAMP:20261104T033533
CREATED:20200204T105233Z
LAST-MODIFIED:20200310T110816Z
UID:1512-1584968400-1584972000@www.research-for-children.de
SUMMARY:CANCELLED: Max Planck Seminar: Hematopoietic stem cells under inflammatory stress (Marieke Essers)
DESCRIPTION:“My group focuses on understanding the link of inflammation and the  hematopoietic stem cell (HSC) compartment via the effect of  pro-inflammatory cytokines on quiescent HSCs and their bone marrow  niche. Investigating the effect of stress-induced pro-inflammatory  cytokines on HSCs and their niche will allow us to better understand  what the mechanisms are by which HSCs are reassuring the successful  restoration of the blood system and how HSCs are protected from  pathogenic insults.” \n\n\n\nLocation: MPI-IE (Main Lecture Hall) \n\n\n\nHosts: Eirini Trompouki & Nina Cabezas-Wallscheid  \n\n\n\nhttps://www.ie-freiburg.mpg.de/events/23519/4815845
URL:https://www.research-for-children.de/event/max-planck-seminar-hematopoietic-stem-cells-under-inflammatory-stress-marieke-essers/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200312T160000
DTEND;TZID=Europe/Berlin:20200312T164500
DTSTAMP:20261104T033533
CREATED:20200205T132003Z
LAST-MODIFIED:20200310T110747Z
UID:1543-1584028800-1584031500@www.research-for-children.de
SUMMARY:CANCELLED: Freiburg Center for Rare Diseases: "Inflammation als gemeinsamer Nenner bei renalen Ziliopathien" (Wolgang Kühn)
DESCRIPTION:Vortragsreihe: „FZSE – Fortbildung und Forschung“\n\n\n\nDas Freiburg Zentrum für Seltene Erkrankungen veranstaltet mehrere wissenschaftliche Vorträge. Sehen Sie hier alle Termine \n\n\n\n Das Freiburg Zentrum für Seltene Erkrankungen (FZSE)  veranstaltet eine wissenschaftliche Vortragsreihe mit dem Namen „FZSE –  Fortbildung und Forschung“.   \n\n\n\nDie monatlich stattfindenden Vorträge im einzelnen: \n\n\n\n13. Februar 2020: Prof. Dr. Daniel Böhringer\, Zentrum für Seltene AugenerkrankungenSeltene Erkrankungen der Hornhaut im Kindesalterum 16 Uhr im Raum Erxleben in der Frauenklinik\n\n\n\n \n\n\n\n12. März 2020: Prof. Dr. Wolgang Kühn\, Zentrum für Genetische NierenerkrankungenInflammation als gemeinsamer Nenner bei renalen Ziliopathienum 16 Uhr im Raum Erxleben in der Frauenklinik\n\n\n\n \n\n\n\n16. April 2020: Dr. Friedrich Kapp\, Zentrum für GefäßfehlbildungenGenetik bei Gefäßfehlbildungen um 16 Uhr im Konferenzraum 1 im Neurozentrum\n\n\n\n \n\n\n\n7. Mai 2020: Prof. Dr. Klaus Warnatz\, Centrum für Chronische Immundefizienz (CCI)Forschungsbericht eGLILDnet/STILPAD um 16 Uhr im Konferenzraum 1 im Neurozentrum\n\n\n\nDie  Veranstaltungen dauern rund 45 Minuten. Eine Anmeldung ist nicht  erforderlich. Die Veranstaltung ist mit einem Fortbildungspunkt  anerkannt. \n\n\n\nhttps://www.uniklinik-freiburg.de/freiburg-zentrum-fuer-seltene-erkrankungen/veranstaltungen.html
URL:https://www.research-for-children.de/event/freiburg-center-for-rare-disases-inflammation-als-gemeinsamer-nenner-bei-renalen-ziliopathien-wolgang-kuhn/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200311T153000
DTEND;TZID=Europe/Berlin:20200311T170000
DTSTAMP:20261104T033533
CREATED:20200206T095218Z
LAST-MODIFIED:20200206T102207Z
UID:1561-1583940600-1583946000@www.research-for-children.de
SUMMARY:Ethik-Café: Spezielle Herausforderungen im Spannungsfeld Therapieentscheidungen – Patientenwille auf Intensivstationen
DESCRIPTION:Für Mitarbeiterinnen und Mitarbeiter des Universitätsklinikums Freiburg und des Universitäts-Herzzentrum Freiburg und Bad Krozingen. \n\n\n\nIm Rahmen der Therapie auf der Intensivstation kommt es immer wieder zu Situationen\, in denen Patienten Maßnahmen ablehnen\, die im Zusammenhang mit Therapiezielen stehen. Sie ziehen sich beispielsweise wichtige Zugänge\, sind wehrhaft oder sogar aggressiv; oder sie sind so passiv\, dass sie im Rahmen einer Selbstaufgabe oder Erschöpfung nicht mehr zu motivieren sind. Wie können wir damit umgehen\, wenn der aktuell gelebte Wille des Patienten scheinbar im Widerspruch zu den vereinbarten Therapiezielen oder dem voraus verfügten Willen steht? \n\n\n\nOrt: Bibliothek Frauenklinik  \n\n\n\nSprecher: Dr. Corinna Lang\, UHZ und Andreas Hausmann\, pflegepädagogische Leitung MIT \n\n\n\nAuf Wunsch erhalten Sie eine Teilnahmebescheinigung und die Bestätigung über Fortbildungspunkte pro Veranstaltung. \n\n\n\nDie Teilnahme ist kostenfrei\, bitte mündlich oder per E-Mail anmelden. \n\n\n\nAnmeldung:Akademie für Medizinische BerufeFachbereich FortbildungTelefon: 0761 / 270-22999E-Mail: fortbildung@uniklinik-freiburg.de \n\n\n\nEthik-Café Ansprechpartnerinnen:Ina Waterstradt\, Pflegeexpertin Frauenklinik: ina.charlotte.waterstradt@uniklinik-freiburg.deSilke Winkler\, katholische Klinikseelsorge: silke.winkler@uniklinik-freiburg.de \n\n\n\nhttps://fortbildungskatalog.uniklinik-freiburg.de/KIP/Suche/Alle%20Fortbildungen/DetailStandard/c5ae8454-aaf3-45ea-8138-deb34825a0d7
URL:https://www.research-for-children.de/event/ethik-cafe-spezielle-herausforderungen-im-spannungsfeld-therapieentscheidungen-patientenwille-auf-intensivstationen/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200305T080000
DTEND;TZID=Europe/Berlin:20200306T170000
DTSTAMP:20261104T033533
CREATED:20200205T123213Z
LAST-MODIFIED:20200205T123215Z
UID:1530-1583395200-1583514000@www.research-for-children.de
SUMMARY:Bench and Bed Immunology 2020: Immunotherapies and targeted therapies in autoimmune/inflammatory diseases (Strasbourg)
DESCRIPTION:The Bench and Bed Immunology (BBI) Seminar is dedicated to Master and PhD students and post-doctoral students from the Faculty of Biology\, the Faculty of Medicine\, Pharmacy\, and Dentistry\, including students in double cursus (medical/clinical students or residents in training). \n\n\n\nBBI bridges the gap between basic immunological research and clinical immunology focusing on immunopathology of diseases and their treatments. The BBI is based on the cross-border support by the Franco-German University (UFA). It is organized and held by basic researchers in Immunology and clinician scientists from Strasbourg\, Freiburg\, Mainz\, Heidelberg and Basel. \n\n\n\nThe focus of BBI 2020 will be “Targeted therapies in autoimmune/inflammatory diseases” (5th-6th March\, 2020\, in Strasbourg). The language of the talks will be English. There will be seminars given by great french or german speakers\, describing targets and new therapies. \n\n\n\nEvery participating student is invited to prepare a short talk about his/her work or describing a published manuscript. The seminar is free for students (transport\, accommodation and meals)\, provided that they actively participate to the seminar with an oral presentation or the presentation of a poster. Participation to BBI allows the validation of doctoral credits for those who are concerned. \n\n\n\nGet more information\, registration info and the program here: https://www.urigroup.eu/upcoming-events/bbi-2020/program/
URL:https://www.research-for-children.de/event/bench-and-bed-immunology-2020-immunotherapies-and-targeted-therapies-in-autoimmune-inflammatory-diseases-strasbourg/
CATEGORIES:Meetings and Conferences
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200229T000000
DTEND;TZID=Europe/Berlin:20200229T235959
DTSTAMP:20261104T033533
CREATED:20200122T082955Z
LAST-MODIFIED:20200122T085238Z
UID:1447-1582934400-1583020799@www.research-for-children.de
SUMMARY:Die Medizinische Fakultät sucht Ärzt*innen für das Mentoring-Jahr 2020/2021: Anmeldung sofort möglich
DESCRIPTION:MentoMed geht im Sommersemester 2020 in die nächste Runde: Das  Mentoring-Programm der Medizinischen Fakultät der Universität Freiburg  sucht Ärzt*innen aus Klinik\, Labor oder Praxis\, die ihr Wissen und ihre  Erfahrungen an Medizinstudierende im klinischen Abschnitt weitergeben  möchten.      \n\n\n\nDie Mentor*innen stehen den Studierenden bei Fragen rund um die \nThemen Karriereplanung\, Doktorarbeit\, Praktisches Jahr (PJ) und \nAuslandsaufenthalt beratend zur Seite. Geplant sind etwa zwei bis drei \nTreffen pro Semester mit einer Dauer von 45 bis 60 Minuten. Das \nMentoring-Programm läuft ein Jahr. Eine Kick-Off-Veranstaltung findet zu\n Beginn des Sommersemesters statt.    \n \n\n\n\nAnmeldungen sind ab sofort bis Ende Februar 2020 möglich. Hier geht es zum Online-Anmeldeformular für Mentor*innen und Studierende. \n \n\n\n\nWeitere Informationen finden Sie unter: www.mentomed.uni-freiburg.de
URL:https://www.research-for-children.de/event/die-medizinische-fakultat-sucht-arztinnen-fur-das-mentoring-jahr-2020-2021/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200227T130000
DTEND;TZID=Europe/Berlin:20200227T140000
DTSTAMP:20261104T033533
CREATED:20200204T105457Z
LAST-MODIFIED:20200204T105459Z
UID:1514-1582808400-1582812000@www.research-for-children.de
SUMMARY:Max Planck Seminar: Nurture your blood stem cells: a tale of zebrafish tails (Julien Bertrand)
DESCRIPTION:“We use the zebrafish as a model to study blood development. \nFertilization occurs externally\, producing large number of embryos that \ncan be easily manipulated. Importantly\, zebrafish blood cells\, as well \nas the molecular pathway necessary to their differentiation have been \nconserved with other vertebrates.  \n\n\n\nThis allowed the generation of \nmany tools to directly follow the behavior of blood cells in the \ntransparent embryos. Thus\, we could show\, by combining several \napproaches\, that embryonic hematopoiesis occurs in four successive \nindependent waves\, culminating with HSC production from a particular \nsubset of endothelial cells: the hemogenic endothelium.  \n\n\n\nWe will  study how this particular hemogenic endothelium is specified from  lateral plate mesoderm\, focusing on the hemangioblast\, to understand the  contribution of this elusive precursor to the adult blood system\, and  study the signals involved in the lineage-decision between the vascular  and blood programs.”  \n\n\n\nLocation: MPI-IE (Main Lecture Hall) \n\n\n\nHost: Eirini Trompouki  \n\n\n\nhttps://www.ie-freiburg.mpg.de/events/23518/4815845
URL:https://www.research-for-children.de/event/max-planck-seminar-nurture-your-blood-stem-cells-a-tale-of-zebrafish-tails-julien-bertrand/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200222T100000
DTEND;TZID=Europe/Berlin:20200222T140000
DTSTAMP:20261104T033533
CREATED:20200206T124233Z
LAST-MODIFIED:20200206T124235Z
UID:1579-1582365600-1582380000@www.research-for-children.de
SUMMARY:International Rare Disease Day 2020 / Internationaler Tag der Seltenen Erkrankungen 2020
DESCRIPTION:Gemeinsam stark für Patienten mit Seltenen Erkrankungen\n\n\n\nGroßer Hörsaal\, Zentrum für Kinder- und Jugendmedizin\, Universitätsklinikum Freiburg \n\n\n\nFreitag\, 21.02.20\, 12:00-18:00 UhrVorstellung des Freiburg Zentrum für Seltene Erkrankungen (FZSE) für Ärzte & Interessierte Samstag\, 22.02.20\, 10:00-14:00 UhrSeltene Erkrankungen bei Kindern\, eine besondere Herausforderung für Eltern\, Ärzte und Gesellschaft \n\n\n\nMehr Infos und das Programm finden Sie hier: https://www.uniklinik-freiburg.de/freiburg-zentrum-fuer-seltene-erkrankungen/veranstaltungen.html
URL:https://www.research-for-children.de/event/international-rare-disease-day-2020-internationaler-tag-der-seltenen-erkrankungen-2020/
CATEGORIES:Meetings and Conferences,Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200221T120000
DTEND;TZID=Europe/Berlin:20200221T173000
DTSTAMP:20261104T033533
CREATED:20200205T132607Z
LAST-MODIFIED:20200206T124114Z
UID:1553-1582286400-1582306200@www.research-for-children.de
SUMMARY:International Rare Disease Day 2020 / Internationaler Tag der Seltenen Erkrankungen 2020
DESCRIPTION:Gemeinsam stark für Patienten mit Seltenen Erkrankungen\n\n\n\nGroßer Hörsaal\, Zentrum für Kinder- und Jugendmedizin\, Universitätsklinikum Freiburg \n\n\n\nFreitag\, 21.02.20\, 12:00-18:00 UhrVorstellung des Freiburg Zentrum für Seltene Erkrankungen (FZSE) für Ärzte & Interessierte Samstag\, 22.02.20\, 10:00-14:00 UhrSeltene Erkrankungen bei Kindern\, eine besondere Herausforderung für Eltern\, Ärzte und Gesellschaft \n\n\n\nMehr Infos und das Programm finden Sie hier: https://www.uniklinik-freiburg.de/freiburg-zentrum-fuer-seltene-erkrankungen/veranstaltungen.html
URL:https://www.research-for-children.de/event/internationaler-tag-der-seltenen-erkrankungen-2020/
CATEGORIES:Meetings and Conferences,Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200218T140000
DTEND;TZID=Europe/Berlin:20200218T150000
DTSTAMP:20261104T033533
CREATED:20200205T122851Z
LAST-MODIFIED:20200205T122856Z
UID:1527-1582034400-1582038000@www.research-for-children.de
SUMMARY:NeuroMAC: The role of progranulin in microglial phagocytosis of apoptotic cells (Lis de Weer\, Calgary)
DESCRIPTION:Talk by Lis de Weer (University of Calgary\, Alberta\, Canada) on The Role of progranulin in microglial phagocytosis of apoptotic cells. \n\n\n\nLocation:   Konferenzraum 2 – Neurozentrum\, Breisacher Str. 64\, Freiburg  \n\n\n\nHost: Marco Prinz \n\n\n\n\nNeuroMac Lecture Series Freiburg – Lis de Weerd
URL:https://www.research-for-children.de/event/neuromac-the-role-of-progranulin-in-microglial-phagocytosis-of-apoptotic-cells-lis-de-weer-calgary/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200218T120000
DTEND;TZID=Europe/Berlin:20200218T130000
DTSTAMP:20261104T033533
CREATED:20200205T122246Z
LAST-MODIFIED:20200205T122325Z
UID:1525-1582027200-1582030800@www.research-for-children.de
SUMMARY:CIBSS Seminar: “Opto-chemical control of immune cell activation and signalling dynamics (John James\, Warwick)
DESCRIPTION:Speaker: Dr. John James (Warwick Medical School\, UK) \n\n\n\nHost: Prof. Dr. Maja Köhn (Institute of Biology III) \n\n\n\nLocation: SR 00.023\, Signalhaus Freiburg\, Schänzlestr 18\, 79104 Freiburg  \n\n\n\nhttps://www.cibss.uni-freiburg.de/events/cibss-seminar-series/1802-cibss-seminar/
URL:https://www.research-for-children.de/event/cibss-seminar-opto-chemical-control-of-immune-cell-activation-and-signalling-dynamics-john-james-warwick/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200218T000000
DTEND;TZID=Europe/Berlin:20200218T235900
DTSTAMP:20261104T033533
CREATED:20200113T082839Z
LAST-MODIFIED:20200113T122817Z
UID:1375-1581984000-1582070340@www.research-for-children.de
SUMMARY:EJP RD Joint Transnational Call: “Pre-clinical Research to Develop Effective Therapies for Rare Diseases”
DESCRIPTION:The ERA-Net E-Rare has successfully implemented ten Joint \nTransnational Calls for rare disease research projects since 2006. This \neffort continues in the framework of the European Joint Programme on Rare Diseases (EJP RD)\n that has been established to further help in coordinating the research \nefforts of European\, Associated and non-European countries in the field \nof rare diseases and implement the objectives of the International Rare Disease Research Consortium (IRDiRC). \n\n\n\nThe aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise\, with a clear future benefit for patients. \n\n\n\nThe deadline for registration and submission of pre-proposals is the 18th of February 2020.  \n\n\n\nResearch proposals must cover at least one of the following areas: \n\n\n\nDevelopment of novel therapies in a preclinical setting (including \nsmall molecules\, repurposing drugs\, cell and gene advanced therapies) \nfocusing on condition(s) with unmet medical needsUse of disease models suitable for medicinal product’s development according to EMA guidelinesDevelopment of predictive and pharmacodynamics (PD) biomarkers (with\n appropriate analytical methods e.g. OMICS) in a preclinical setting \n(e.g. in the validated model or in pre-collected human samples) for \nmonitoring the efficiency of the therapy. The model chosen must mimic \nthe human diseases and be transposable so that the biomarker identified \nin animals can be valid for humansProof of principle studies fostering an early (pre-clinical) stage \nof drug development (excluding interventional clinical trials of phase \n1-4).\n\n\n\nThe following approaches and topics are excluded from the scope of the call: \n\n\n\nTherapeutic approaches concerning rare infectious diseases\, rare  cancers and rare adverse drug events in treatments of common diseasesInterventional clinical trialsSurgery or radiation therapiesStudies that focus on research to accelerate diagnosis or to set up  new registry/cohort studies to explore disease progression and  mechanisms as these were the focus of JTC 2019.Rare neurodegenerative diseases which are within the main focus of the Joint Programming Initiative on Neurodegenerative Disease Research (JPND).  These are: Alzheimer’s disease and other dementias; Parkinson’s disease  (PD) and PD-related disorders; Prion disease; Motor Neuron Diseases;  Huntington’s disease; Spinal Muscular Atrophy and dominant forms of  Spinocerebellar Ataxia.  Interested researchers should refer to the  relevant JPND calls.       Childhood dementias/neurodegenerative diseases are not excluded.\n\n\n\nFor more information\, please visit the EJP RD webpage here.
URL:https://www.research-for-children.de/event/ejp-rd-joint-transnational-call-pre-clinical-research-to-develop-effective-therapies-for-rare-diseases/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200215T000000
DTEND;TZID=Europe/Berlin:20200215T235900
DTSTAMP:20261104T033533
CREATED:20191212T110123Z
LAST-MODIFIED:20191212T110125Z
UID:1349-1581724800-1581811140@www.research-for-children.de
SUMMARY:Fritz Thyssen Stiftung: Molecular causes in the development of illnesses
DESCRIPTION:I n accordance with one of the desires of the donors\, special attention is  devoted by the foundation institutions to medical research. At present  the foundation is focusing its support on the field of “Molecular causes  in the development of illnesses”.  This programme supports molecular  biological studies of illnesses whose development is based on genetic  defects or with which gene variants contribute to the development of  complex illnesses.  \n\n\n\nMore information about this research focus of the Foundation can be found here: https://www.fritz-thyssen-stiftung.de/en/funding/promotion-areas/medicine-and-natural-sciences/ \n\n\n\nMore information about submitting an application can be found here: https://www.fritz-thyssen-stiftung.de/en/funding/types-of-support/support-of-projects/
URL:https://www.research-for-children.de/event/fritz-thyssen-stiftung-molecular-causes-in-the-development-of-illnesses/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200214T000000
DTEND;TZID=Europe/Berlin:20200214T235900
DTSTAMP:20261104T033533
CREATED:20191127T110107Z
LAST-MODIFIED:20191127T110514Z
UID:1300-1581638400-1581724740@www.research-for-children.de
SUMMARY:Geschlechtsspezifische Besonderheiten bei Gesundheitsförderung und Prävention in Lebenswelten
DESCRIPTION:Wissenschaftliche Erkenntnisse \nzeigen\, dass das Geschlecht sowohl Einfluss auf den Erhalt der \nGesundheit als auch auf die Entstehung von Krankheiten hat. Dies kann zu\n ungleichen Gesundheitschancen beitragen. Bislang werden \ngeschlechtsspezifische Besonderheiten bei der Entwicklung und Umsetzung \nvon Maßnahmen der Gesundheitsförderung und Prävention noch wenig \nberücksichtigt. Ein besseres Verständnis geschlechtsspezifischer \nBesonderheiten sowie Erkenntnisse zu Ursachen und Auswirkungen sind \nhierfür erforderlich. \n\n\n\nDas GKV-Bündnis für Gesundheit fördert daher\n interdisziplinäre und praxisorientierte Forschungsvorhaben\, die \ngeschlechtsspezifische Besonderheiten untersuchen und adäquate Ansätze \nfür Maßnahmen der lebensweltbezogenen Gesundheitsförderung und \nPrävention entwickeln. \n\n\n\nDas Förderangebot richtet sich an: \n\n\n\nStaatliche und nichtstaatliche (Fach-)HochschulenUniversitäre und außeruniversitäre ForschungseinrichtungenGemeinnützige Körperschaften (z. B. eingetragene Vereine\, Stiftungen und gemeinnützige GmbHs)\n\n\n\nhttps://www.gkv-buendnis.de/forschung-im-buendnis/foerderung-forschungsvorhaben/
URL:https://www.research-for-children.de/event/geschlechtsspezifische-besonderheiten-bei-gesundheitsforderung-und-pravention-in-lebenswelten/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200213T160000
DTEND;TZID=Europe/Berlin:20200213T164500
DTSTAMP:20261104T033533
CREATED:20200205T131812Z
LAST-MODIFIED:20200219T083701Z
UID:1541-1581609600-1581612300@www.research-for-children.de
SUMMARY:Freiburg Center for Rare Diseases: "Seltene Erkrankungen der Hornhaut im Kindesalter" (Daniel Böhringer)
DESCRIPTION:Vortragsreihe: „FZSE – Fortbildung und Forschung“\n\n\n\nDas Freiburg Zentrum für Seltene Erkrankungen veranstaltet mehrere wissenschaftliche Vorträge. Sehen Sie hier alle Termine \n\n\n\n Das Freiburg Zentrum für Seltene Erkrankungen (FZSE)  veranstaltet eine wissenschaftliche Vortragsreihe mit dem Namen „FZSE –  Fortbildung und Forschung“.   \n\n\n\nDie monatlich stattfindenden Vorträge im einzelnen: \n\n\n\n13. Februar 2020: Prof. Dr. Daniel Böhringer\, Zentrum für Seltene AugenerkrankungenSeltene Erkrankungen der Hornhaut im Kindesalterum 16 Uhr im Raum Erxleben in der Frauenklinik\n\n\n\n \n\n\n\n12. März 2020: Prof. Dr. Wolgang Kühn\, Zentrum für Genetische NierenerkrankungenInflammation als gemeinsamer Nenner bei renalen Ziliopathienum 16 Uhr im Raum Erxleben in der Frauenklinik\n\n\n\n \n\n\n\n16. April 2020: Dr. Friedrich Kapp\, Zentrum für GefäßfehlbildungenGenetik bei Gefäßfehlbildungen um 16 Uhr im Konferenzraum 1 im Neurozentrum\n\n\n\n \n\n\n\n7. Mai 2020: Prof. Dr. Klaus Warnatz\, Centrum für Chronische Immundefizienz (CCI)Forschungsbericht eGLILDnet/STILPAD um 16 Uhr im Konferenzraum 1 im Neurozentrum\n\n\n\nDie  Veranstaltungen dauern rund 45 Minuten. Eine Anmeldung ist nicht  erforderlich. Die Veranstaltung ist mit einem Fortbildungspunkt  anerkannt. \n\n\n\nhttps://www.uniklinik-freiburg.de/freiburg-zentrum-fuer-seltene-erkrankungen/veranstaltungen.html
URL:https://www.research-for-children.de/event/freiburg-center-for-rare-disases-seltene-erkrankungen-der-hornhaut-im-kindesalter-daniel-bohringer/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200213T130000
DTEND;TZID=Europe/Berlin:20200213T140000
DTSTAMP:20261104T033533
CREATED:20200204T105011Z
LAST-MODIFIED:20200204T105014Z
UID:1510-1581598800-1581602400@www.research-for-children.de
SUMMARY:Max Planck Seminar: Multi-Omics Single-Cell Computational Biology (Laleh Haghverdi)
DESCRIPTION:Laleh Haghverdi received her PhD in Mathematics from the  Technical University of Munich. She has a background in physics and has  been working on single cell gene expression data analysis over the few  past years. Currently\, she works at European Molecular Biology  Laboratory in Heidelberg (Huber Group & EMBL-EBI). The expert in  single cell data analysis uses the modular architecture of gene  regulatory networks and several gene interactions to develope a  framework for accurate cell type recognition based on geometric deep  learning. \n\n\n\nLocation:      MPI-IE (Main Lecture Hall) \n\n\n\nHost: Rudolf Grosschedl   \n\n\n\nhttps://www.ie-freiburg.mpg.de/events/23640/4815845
URL:https://www.research-for-children.de/event/max-planck-seminar-multi-omics-single-cell-computational-biology-laleh-haghverdi/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200213T080000
DTEND;TZID=Europe/Berlin:20200215T170000
DTSTAMP:20261104T033533
CREATED:20190905T084416Z
LAST-MODIFIED:20191127T110603Z
UID:786-1581580800-1581786000@www.research-for-children.de
SUMMARY:Conference: The Network for Evidence-Based Medicine: „Useful patient-relevant research“
DESCRIPTION:We are delighted that the annual conference of the Network will take place for the first time in Switzerland. From February 13 to 15\, 2020 we will address the question „How do we get the evidence we need?“ under the main theme „Useful patient-relevant research“ at the University Hospital Basel.   \n\n\n\nFor further information\, please visit the conference website: https://www.ebm-kongress.de/invitation/
URL:https://www.research-for-children.de/event/conference-of-the-network-for-evidence-based-medicine-useful-patient-relevant-research/
CATEGORIES:Meetings and Conferences
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200206T160000
DTEND;TZID=Europe/Berlin:20200206T170000
DTSTAMP:20261104T033533
CREATED:20200205T121709Z
LAST-MODIFIED:20200205T121711Z
UID:1520-1581004800-1581008400@www.research-for-children.de
SUMMARY:Biologisches Kolloquium: “Dynamics of phagocytes during central nervous system autoimmune inflammation (Giuseppe Locatelli)
DESCRIPTION:On February 6th 2020\, at 16:00\, Prof. Giuseppe Locatelli\, Theodor Kocher Institut\, Universität Bern will give a talk about: Dynamics of phagocytes during central nervous system autoimmune inflammation. \n\n\n\nHe will be hosted by Dr. Tuan Leng Tay  \n\n\n\nLocation:  Hörsaal Zoologie\, Hauptstr. 1\,  Freiburg  \n\n\n\nhttps://www.bio.uni-freiburg.de/events/20200206-kolloq
URL:https://www.research-for-children.de/event/biologisches-kolloquium-dynamics-of-phagocytes-during-central-nervous-system-autoimmune-inflammation-giuseppe-locatelli/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200204T000000
DTEND;TZID=Europe/Berlin:20200204T235900
DTSTAMP:20261104T033533
CREATED:20191212T092049Z
LAST-MODIFIED:20191212T092051Z
UID:1345-1580774400-1580860740@www.research-for-children.de
SUMMARY:ERC Consolidator Grants
DESCRIPTION:Are you a scientist who wants to consolidate your independence  by establishing a research team and continuing to develop a success  career in Europe? The ERC Consolidator Grant could be for you. You can  also apply if you have recently created an independent\, excellent  research team and want to strengthen it.  \n\n\n\nResearchers of any nationality with 7-12 years of experience since completion of PhD (Extensions are possible under certain circumstances — see the latest ERC Work Programme)\, a scientific track record showing great promise and an excellent research proposal.  \n\n\n\n\n	Consolidator Grants may be awarded up to € 2 million for a period of 5 years.\n (pro rata for projects of shorter duration). However\, an additional € 1\n million can be made available to cover eligible “start-up” costs for \nresearchers moving from a third country to the EU or an associated \ncountry and/or the purchase of major equipment and/or access to large \nfacilities and/or other major experimental and field work costs. \n\n\n\nFor more information\, please see the ERC website here: https://erc.europa.eu/funding/consolidator-grants
URL:https://www.research-for-children.de/event/erc-consolidator-grants/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200127T103000
DTEND;TZID=Europe/Berlin:20200127T120000
DTSTAMP:20261104T033533
CREATED:20200123T091618Z
LAST-MODIFIED:20200123T091620Z
UID:1452-1580121000-1580126400@www.research-for-children.de
SUMMARY:Info Event: Elite Program for Post-docs from the Baden-Württemberg Stiftung
DESCRIPTION:Das Programm richtet \nsich an herausragend qualifizierte Nachwuchswissenschaftler/-innen\, die \neine Hochschullehrerlaufbahn anstreben. \n\n\n\nDie Ausschreibung ist offen für alle Fachbereiche\, bezieht aber nicht den Bereich der klinischen Medizin\n mit ein. Im Eliteprogramm können jedoch \nlebenswissenschaftliche/medizinische Vorhaben finanziert werden\, die der\n Grundlagenforschung zuzuordnen sind. Eine klinische Tätigkeit\, in der \neine Arzt-Patient-Beziehung gegeben ist\, bleibt ausgeschlossen. \n\n\n\nAus den Anträgen muss \ndeutlich eine über dem Durchschnitt liegende Befähigung zur \nwissenschaftlichen Karriere erkennbar sein. Voraussetzung ist\, dass die \nBewerber/-innen ihr Forschungsvorhaben an einer der \npromotionsberechtigten Hochschulen des Landes durchführen wollen und \nihren Lebensmittelpunkt in Baden-Württemberg haben. \n\n\n\nDie Förderung pro \nVorhaben beträgt bis zu 150.000 € für drei Jahre die als \nInfrastrukturmittel für die Ausstattung der Postdoktorandinnen und \nPostdoktoranden gewährt werden. Infrastrukturmittel sind Personalmittel\,\n Reisemittel\, Sachmittel und Investitionsmittel. Die Stelle der \nPostdoktorandin bzw. des Postdoktoranden selbst kann nicht aus den \nMitteln des Eliteprogramms bezahlt werden. \n\n\n\nEin Eigenanteil von \nmindestens 10% muss durch die Einrichtung (Klinik\, Institut) selbst \naufgebraucht werden\, wobei die für die Antragsteller/-innen \naufgewendeten Personalmittel hierauf nicht angerechnet werden dürfen. \n\n\n\nFür Interessierte an diesem Programm findet am Montag\, den 27.01.2020\, 10.30–12 Uhr\, eine Informationsveranstaltung im Seminarraum der Freiburg Research Services (Friedrichstraße 41-43\, 2. OG\, Raum 02.003) statt. Anmeldungen werden bis zum 23.01.2020 per E-Mail an merle.ueding@frs.uni-freiburg.de erbeten. \n\n\n\nBitte informieren Sie \ndas Forschungsdekanat frühzeitig über Ihre geplante Antragstellung. Sie \nerhalten dann weitere Informationen\, welche Ihnen die Antragstellung \nerleichtern. \n\n\n\nDie Zahl der Anträge \npro Hochschule ist begrenzt. Die Universität Freiburg kann bis zu 7 \nBewerbungen einreichen. Anträge werden daher einer universitätsinternen \nKommission zur Auswahl vorgelegt\, die über die Weiterleitung der Anträge\n entscheidet. Von Wiedereinreichungen bitten wir abzusehen. \n\n\n\nBitte reichen Sie Ihren Antrag ausschließlich digital beim Forschungsdekanat (forschungsdekanat@uniklinik-freiburg.de) ein. \n\n\n\nRückfragen können Sie jederzeit gerne unter Tel.-Nr. 0761/270-72450 oder per Email (forschungsdekanat@uniklinik-freiburg.de) an Herrn Hölzl stellen. \n\n\n\nEinreichungsfrist beim Forschungsdekanat: 18.03.2020 \n\n\n\nhttp://www.med.uni-freiburg.de/de/forschung/forschungsfoerderung/national/national#elite
URL:https://www.research-for-children.de/event/info-event-elite-program-for-post-docs-from-the-baden-wurttemberg-stiftung/
CATEGORIES:Funding Deadlines
END:VEVENT
END:VCALENDAR